Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
4.190
-3.510 (-45.58%)
Jun 30, 2026, 10:02 AM EDT - Market open
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $111.87 million as of June 30, 2026. Its market cap has increased by 36.10% in one year.
Market Cap
111.87M
Enterprise Value
151.82M
1-Year Change
36.10%
Ranking
Category
Stock Price
$4.19
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $111.87M, an increase of 68.26%. That is a compound annual growth rate of 11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 111.87M | -9.78% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 197.68M |
| Arcturus Therapeutics Holdings | 195.55M |
| MediWound | 195.23M |
| Equillium | 192.84M |
| Oramed Pharmaceuticals | 191.12M |
| Humacyte | 191.07M |
| NovaBridge Biosciences | 189.66M |
| Precision BioSciences | 188.10M |